Moderna, Pfizer Stocks Fall After CDC Panel Flags Heart Inflammation Risk In Young Adults Receiving COVID-19 Vaccine

By Shanthi Rexaline

Shares of COVID-19 vaccine companies Moderna Inc MRNA 3.82%, Pfizer Inc. PFE 0.44% and BioNTech SE – ADR BNTX 0.75% are moving sharply lower Wednesday.

What Happened: Administering of mRNA vaccines, the class of vaccines developed by Moderna and Pfizer-BioNTech, resulted in higher observed vs. expected myocarditis/pericarditis cases in 16 to 24 years olds following dose two of mRNA vaccines, CDC’s COVID-19 Vaccine Safety Technical Work Group said in a report.

The report was prepared for discussion by CDC’s Advisory Committee on Immunization Practices, which is being held Wednesday to look into a possible link between mRNA vaccines and a heart condition.

Since April, there have been increased reports of cases of inflammation of the heart — myocarditis and pericarditis — after being administered either Pfizer-BioNTech or Moderna’s mRNA vaccines, the panel said in the report.

Via https://www.benzinga.com/general/biotech/21/06/21690245/moderna-pfizer-stocks-fall-after-cdc-panel-flags-heart-inflammation-risk-in-young-adults-receivin